Disord. 2009; 39(3): 405-413. doi: 10.1007/s10803-008-0637-8.
15. Mazurek MO, Vasa RA, Kalb LG, et al. Anxiety, sensory over-
responsivity, and gastrointestinal problems in children with autism spectrum
disorders. J Abnorm Child Psychol. 2013; 41(1): 165-176. doi: 10.1007/s10802-
012-9668-x.
16. Horvath K and Perman JA. Autism and gastrointestinal symptoms. Curr
Gastroenterol Rep. 2002; 4(3): 251-8.
17. Pramparo T, Pierce K, Lombardo MV, et al. Prediction of autism by
translation and immune/inflammation coexpressed genes in toddlers from
pediatric community practices. JAMA Psychiatry. 2015; 72(4): 386-394. doi:
10.1001/jamapsychiatry.2014.3008.
18. Herbert MR et al. Dissociations of cerebral cortex, subcortical and
cerebral white matter volumes in autistic boys. Brain. 2003; 126(5): 1182-1192.
19. Herbert MR. Large brains in autism: The challenge of pervasive
abnormality. The Neuroscientist. 2005; 11(5): 417-440.
20. Kern JK et al. Relevance of Neuroinflammation and encephalitis in
autism. Frontiers in Cellular Neuroscience. 2016; 9.
21. Di Marco B, Bonaccorso CM, Aloisi E, D’Antoni S, Catania MV.
Neuro-Inflammatory mechanisms in developmental disorders associated with
intellectual disability and autism spectrum disorder: A Neuro- immune
perspective. CNS & Neurological Disorders - Drug Targets. 2016; 15(4): 448-
463.
22. Ichim, TE et al. Stem cell therapy for autism. J Transl Med, 2007. 5: p.
30.
23. Madrigal M, Rao KS, and Riordan NH. A review of therapeutic effects
of mesenchymal stem cell secretions and induction of secretory modification by
different culture methods. J Transl Med. 2014; 12(1): 260. doi: 10.1186/s12967-
014-0260-8.
24. Liang J, Zhang H, Hua B, et al. Allogeneic mesenchymal stem cells
transplantation in treatment of multiple sclerosis. Mult Scler. 2009; 15(5): 644-6.
